You are here

Tivicay

FDA approves dispersible tablet formulation of dolutegravir for HIV in children

Pharmaceutical Business Review

Mon, 06/15/20 - 10:56 am

ViiV Healthcare

Top GSK/ViiV scientist who co-invented an HIV blockbuster books a trip to biotech

Endpoints

Wed, 09/25/19 - 09:16 am

4 Biggest HIV Drugs of 2024: Which Stocks Are Poised to Profit?

Motley Fool

Mon, 07/16/18 - 09:21 am

Gilead Sciences

GlaxoSmithKline's next-generation HIV battle against Gilead is already taking a toll on growth

Fierce Pharma

Sat, 04/28/18 - 12:13 pm

Gilead Sciences

Are Glaxo's Successful New Drugs Enough to Drive Growth?

Yahoo/Zacks.com

Wed, 08/23/17 - 10:14 pm

GlaxoSmithKline gambles against Gilead with risky bet on two-drug HIV combos

Fierce Pharma

Wed, 09/7/16 - 09:37 am

Gilead Sciences

GSK's modern HIV drug to be rolled out in Botswana

Yahoo/Reuters

Fri, 06/3/16 - 09:55 am

Viiv Healthcare expands access to HIV drug through patent pooling

BioPharma Dive

Wed, 04/27/16 - 02:09 pm

ViiV Healthcare

A Pivotal Moment For GlaxoSmithKline

Seeking Alpha

Thu, 08/27/15 - 11:26 am

Bring out the confetti: 7 of 2013's launches will join Sovaldi, Tecfidera in blockbuster land

Fierce Pharma Marketing

Thu, 06/26/14 - 10:21 am

Breo Ellipta and Anoro Ellipta

Glaxo, Pfizer's HIV Treatment Recommended by EU Regulator

Bloomberg

Fri, 11/22/13 - 10:22 am

Glaxo Seeks EU Approval for HIV Drug

Yahoo/Zacks

Tue, 10/29/13 - 10:44 am

ViiV Healthcare

Can This HIV Drug Challenge Gilead's Domination?

Motley Fool

Wed, 08/28/13 - 08:48 am

ViiV Healthcare

Glaxo's Tivicay Gets Approval

Yahoo/Zacks

Sat, 08/17/13 - 11:24 am

FDA Delivers a Double Dose of Good News in the Fight Against HIV

Motley Fool

Wed, 08/14/13 - 09:15 am

Alere Determine

ViiV Healthcare

Glaxo Wins U.S. FDA Approval for New Daily HIV Therapy

Bloomberg

Mon, 08/12/13 - 05:26 pm

ViiV Healthcare